Reference health

Fractional model for pharmacokinetics of high dose methotrexate in children with acute lymphoblastic leukaemia

https://doi.org/10.1016/j.cnsns.2014.08.014
CiteStamped reference-health badge
53/53 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

12 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 53 checked references that resolve
resolves10.1002/1097-0142(19870701)60:1<5::AID-CNCR2820600103>3.0.CO;2-D
A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemia
resolves10.4065/71.1.69
Methotrexate for Inflammatory Bowel Disease: Pharmacology and Preliminary Results
resolves10.1016/S0305-7372(83)80032-2
The clinical pharmacology of methotrexate
resolves10.1002/pbc.10443
Methotrexate pharmacokinetics and survival in osteosarcoma
resolves10.1371/journal.pcbi.1001019
Modeling Mechanisms of In Vivo Variability in Methotrexate Accumulation and Folate Pathway Inhibition in Acute Lymphoblastic Leukemia Cells
resolves10.1080/028418698429586
Clinical and Pharmacokinetic Risk Factors for High-dose Methotrexate-induced Toxicity in Children with Acute Lymphoblastic Leukemia: A Logistic Regression Analysis
resolves10.1080/pho.21.1.77.83
Hemostatic Side Effects of High-Dose Methotrexate in Childhood Acute Lymphoblastic Leukemia
resolves10.1182/blood-2007-07-102525
High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia
resolves10.1200/JCO.2010.32.5340
Shortening Infusion Time for High-Dose Methotrexate Alters Antileukemic Effects: A Randomized Prospective Clinical Trial
resolves10.1093/clinchem/42.8.1322
Concepts in use of high-dose methotrexate therapy
resolves10.1093/annonc/mdm466
Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer
resolves10.1111/j.1525-1470.2008.00629.x
Systemic Methotrexate Treatment in Childhood Psoriasis: Further Experience in 24 Children from India
resolves10.1634/theoncologist.11-6-694
Understanding and Managing Methotrexate Nephrotoxicity
resolves10.1046/j.1365-2125.1999.00884.x
Therapeutic drug monitoring of antimetabolic cytotoxic drugs
resolves10.1093/clinchem/39.11.2419
Therapeutic drug monitoring in cancer management
resolves10.1002/1097-0142(1967)20:2<233::AID-CNCR2820200209>3.0.CO;2-8
Continuous infusion of methotrexate in children with acute leukemia
resolves10.2165/00003088-200645120-00007
Population Pharmacokinetics of High-Dose Methotrexate in Children with Acute Lymphoblastic Leukaemia
resolves10.1002/bdd.678
High dose methotrexate population pharmacokinetics and Bayesian estimation in patients with lymphoid malignancy
resolves10.1007/s00280-006-0394-3
A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia
resolves10.1038/clpt.1983.6
Test dose for predicting high-dose methotrexate infusions
resolves10.1007/s00280-006-0202-0
Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy
resolves10.1111/j.1365-2710.2008.00966.x
Population pharmacokinetics of high-dose methotrexate in Japanese adult patients with malignancies: a concurrent analysis of the serum and urine concentration data
resolves10.1007/s10928-009-9116-x
Fractional kinetics in drug absorption and disposition processes
resolves10.1007/s10928-009-9147-3
A new approach to the compartmental analysis in pharmacokinetics: fractional time evolution of diclofenac
resolves10.1007/s10928-010-9153-5
A commentary on fractionalization of multi-compartmental models
resolves10.1007/s10928-010-9170-4
Fractional kinetics in multi-compartmental systems
resolves10.1007/s10928-010-9155-3
Fractional compartmental models and multi-term Mittag–Leffler response functions
resolves10.1007/s10928-010-9154-4
Remarks on the mass balance for multi-compartmental models; a nonlinear compartmental model
resolves10.1007/s10928-010-9159-z
Fractional dynamics pharmacokinetics–pharmacodynamic models
resolves10.1016/j.cnsns.2011.02.012
Simulation of drug uptake in a two compartmental fractional model for a biological system
resolves10.1007/s13318-011-0057-6
A nonlinear two compartmental fractional derivative model
resolves10.1007/s13318-012-0097-6
Individualization of a pharmacokinetic model by fractional and nonlinear fit improvement
resolves10.1016/j.cnsns.2013.01.004
Two compartmental fractional derivative model with fractional derivatives of different order
resolves10.1007/s10928-013-9340-2
How to avoid unbounded drug accumulation with fractional pharmacokinetics
resolves10.1016/S0006-3495(95)80157-8
A fractional calculus approach to self-similar protein dynamics
resolves10.1007/s10237-005-0011-0
Fractional Calculus in Biomechanics: A 3D Viscoelastic Model Using Regularized Fractional Derivative Kernels with Application to the Human Calcaneal Fat Pad
resolves10.1615/CritRevBiomedEng.v32.10
Fractional Calculus in Bioengineering, Part 1
resolves10.1615/CritRevBiomedEng.v32.i2.10
Fractional Calculus in Bioengineering, Part 2
resolves10.1615/CritRevBiomedEng.v32.i34.10
Fractional Calculus in Bioengineering, Part3
resolves10.1615/CritRevBiomedEng.v36.i1.40
Generalized Functions for the Fractional Calculus
resolves10.1615/CritRevBiomedEng.v35.i6.10
INITIALIZATION, CONCEPTUALIZATION, AND APPLICATION IN THE GENERALIZED (FRACTIONAL) CALCULUS
resolves10.1615/CritRevBiomedEng.v36.i1.50
R-Function Relationships for Application in the Fractional Calculus
resolves10.1109/TIP.2007.904971
Fractional-Order Anisotropic Diffusion for Image Denoising
resolves10.1186/1753-4631-4-3
Fractional-calculus diffusion equation
resolves10.3389/fphys.2010.00012
Fractal physiology and the fractional calculus: a perspective
resolves10.1016/j.chaos.2006.01.098
Fractional-order dynamical models of love
resolves10.1016/j.cnsns.2009.04.029
Dynamical models of happiness with fractional order
resolves10.1115/1.2833910
Advances in System Identification Using Fractional Models
resolves10.1007/BF00493567
Estimation and prediction of blood volume in infants and children
resolves10.1093/bjaceaccp/mkh021
Pharmacokinetics of drug infusions
resolves10.1115/1.1629106
On Viscoelastic Compliant Contact-Impact Models
resolves10.1140/epjst/e2013-01967-y
Fractional calculus: A survey of useful formulas
resolves10.1016/j.camwa.2009.10.030
Application of Post’s formula to optical pulse propagation in dispersive media
The 12 references without a DOI — listed, not checked
no DOI — not checkedMethotrexate-associated liver toxicity in a patient with breast cancer: case report and literature review
no DOI — not checkedThe importance of pharmacokinetic limited sampling models for childhood cancer drug development
no DOI — not checked10.1016/j.cnsns.2014.08.014_b0165
no DOI — not checked10.1016/j.cnsns.2014.08.014_b0200
no DOI — not checkedLe Mehaute A, Tenreiro Machado JA, Trigeassou JC, Sabatier J, editors. Fractional differentiation and its applications. Neusas: Ubooks; 2005.
no DOI — not checked10.1016/j.cnsns.2014.08.014_b0265
no DOI — not checked10.1016/j.cnsns.2014.08.014_b0270
no DOI — not checked10.1016/j.cnsns.2014.08.014_b0280
no DOI — not checked10.1016/j.cnsns.2014.08.014_b0295
no DOI — not checked10.1016/j.cnsns.2014.08.014_b0300
no DOI — not checked10.1016/j.cnsns.2014.08.014_b0320
no DOI — not checked10.1016/j.cnsns.2014.08.014_b0325
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.cnsns.2014.08.014"><img src="https://citestamp.com/citestamped/10.1016/j.cnsns.2014.08.014/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.cnsns.2014.08.014/badge.svg)](https://citestamp.com/citestamped/10.1016/j.cnsns.2014.08.014)